ATOS EPS Estimates
Atossa Therapeutics, Inc.
$2.65
-$0.13(-4.68%)
40
Overall
60
Value
50
Tech
10
Quality
Market Cap
$27.74M
Volume
226.01K
52W Range
$1.70 - $17.25
Target Price
$17.00
ATOS EPS estimates: the consensus estimate for Atossa Therapeutics, Inc.'s current fiscal year is -$3.75 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ATOS EPS Estimates
- EPS estimate, current quarter
- $-0.86
- EPS estimate, next quarter
- $-0.86
- EPS estimate, current year
- $-3.75
- EPS estimate, next year
- $-2.78
- EPS growth, 3-year
- -8.65%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.04 |
| 2024 | $-3.00 |
| 2023 | $-3.60 |
| 2022 | $-3.15 |
| 2021 | $-2.70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATOS | $2.65 | -4.7% | 226.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atossa Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW